Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Knerr, P. J. & van der Donk, W. A. Discovery, biosynthesis, and engineering of lantipeptides. Annu. Rev. Biochem. 81, 479–505 (2012).
Schnell, N. et al. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature 333, 276–278 (1988).
Delves-Broughton, J., Blackburn, P., Evans, R. J. & Hugenholtz, J. Applications of the bacteriocin, nisin. Antonie van Leeuwenhoek 69, 193–202 (1996).
Lubelski, J., Rink, R., Khusainov, R., Moll, G. N. & Kuipers, O. P. Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell Mol. Life Sci. 65, 455–476 (2008).
Brumfitt, W., Salton, M. R. & Hamilton-Miller, J. M. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J. Antimicrob. Chemother. 50, 731–734 (2002).
Goldstein, B. P., Wei, J., Greenberg, K. & Novick, R. Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J. Antimicrob. Chemother. 42, 277–278 (1998).
Mota-Meira, M., LaPointe, G., Lacroix, C. & Lavoie, M. C. MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob. Agents Chemother. 44, 24–29 (2000).
Breukink, E. & De Kruijff, B. Lipid II as a target for antibiotics. Nat. Rev. Drug Discov. 5, 321–332 (2006).
Schneider, T. & Sahl, H. G. Lipid II and other bactoprenol-bound cell wall precursors as drug targets. Curr. Opin. Investig. Drugs 11, 157–164 (2010).
Kramer, N. E. et al. Increased D-alanylation of lipoteichoic acid and a thickened septum are main determinants in the nisin resistance mechanism of Lactococcus lactis. Microbiology 154, 1755–1762 (2008).
Gravesen, A., Sørensen, K., Aarestrup, F. M. & Knøchel, S. Spontaneous nisin-resistant Listeria monocytogenes mutants with increased expression of a putative penicillin-binding protein and their sensitivity to various antibiotics. Microb. Drug Resist. 7, 127–135 (2001).
Khosa, S., Alkhatib, Z. & Smits, S. H. NSR from Streptococcus agalactiae confers resistance against nisin and is encoded by a conserved nsr operon. Biol. Chem. 394, 1543–1549 (2013).
Hsu, S. T. et al. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11, 963–967 (2004).
Brötz, H. et al. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30, 317–327 (1998).
Breukink, E. et al. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286, 2361–2364 (1999).
Hasper, H. E. et al. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313, 1636–1637 (2006).
Wiedemann, I. et al. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276, 1772–1779 (2001).
Garg, N., Tang, W., Goto, Y., Nair, S. K. & van der Donk, W. A. Lantibiotics from Geobacillus thermodenitrificans. Proc. Natl Acad. Sci. USA 109, 5241–5246 (2012).
Hasper, H. E., De Kruijff, B. & Breukink, E. Assembly and stability of nisin-lipid II pores. Biochemistry 43, 11567–11575 (2004).
Brötz, H. & Sahl, H. G. New insights into the mechanism of action of lantibiotics—diverse biological effects by binding to the same molecular target. J. Antimicrob. Chemother. 46, 1–6 (2000).
Yuan, J., Zhang, Z. Z., Chen, X. Z., Yang, W. & Huan, L. D. Site-directed mutagenesis of the hinge region of nisinZ and properties of nisinZ mutants. Appl. Microbiol. Biotechnol. 64, 806–815 (2004).
Oman, T. J. & van der Donk, W. A. Insights into the mode of action of the two-peptide lantibiotic haloduracin. ACS Chem. Biol. 4, 865–874 (2009).
Field, D., Connor, P. M., Cotter, P. D., Hill, C. & Ross, R. P. The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol. Microbiol. 69, 218–230 (2008).
Chen, L. et al. Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate. Proc. Natl Acad. Sci. USA 100, 5658–5663 (2003).
Lian, L. Y. et al. Solution structures of nisin A and its two major degradation products determined by n.m.r. Biochem. J. 283, 413–420 (1992).
Rink, R. et al. Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl. Environ. Microbiol. 73, 5809–5816 (2007).
Acknowledgements
This work was supported by the National Institutes of Health (R01 GM58822 to WAV and R01 GM076710 to SW). CGG was supported by the National Institutes of Health under Ruth L Kirschstein National Research Service Award 5 T32 GM070421 from the National Institute of General Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study is dedicated to Professor Christopher T Walsh for his inspiring leadership in natural product biosynthesis and mechanistic enzymology.
Supplementary Information accompanies the paper on The Journal of Antibiotics website
Supplementary information
Rights and permissions
About this article
Cite this article
Garg, N., Oman, T., Andrew Wang, TS. et al. Mode of action and structure–activity relationship studies of geobacillin I. J Antibiot 67, 133–136 (2014). https://doi.org/10.1038/ja.2013.112
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2013.112
Keywords
This article is cited by
-
Biomanufacturing process for the production of bacteriocins from Bacillaceae family
Bioresources and Bioprocessing (2020)
-
Complement-dependent outer membrane perturbation sensitizes Gram-negative bacteria to Gram-positive specific antibiotics
Scientific Reports (2019)
-
Heterologous biosynthesis and characterization of a glycocin from a thermophilic bacterium
Nature Communications (2019)
-
Lipid-II Independent Antimicrobial Mechanism of Nisin Depends On Its Crowding And Degree Of Oligomerization
Scientific Reports (2016)